{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:13:08Z","timestamp":1648588388935},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12672-015-0222-5","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T13:49:47Z","timestamp":1430833787000},"page":"142-152","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors"],"prefix":"10.1007","volume":"6","author":[{"given":"Dannielle H.","family":"Upton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily S.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily K.","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty A.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viive M.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"222_CR1","first-page":"2433","volume":"4","author":"A Berchuck","year":"1998","unstructured":"Berchuck A, Heron KA, Carney ME et al (1998) Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 4:2433\u20132437","journal-title":"Clin Cancer Res"},{"key":"222_CR2","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/cncr.21536","volume":"104","author":"T Pal","year":"2005","unstructured":"Pal T, Permuth-Wey J, Betts JA et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807\u20132816","journal-title":"Cancer"},{"key":"222_CR3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365\u20131372","journal-title":"J Natl Cancer Inst"},{"key":"222_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1006\/gyno.2002.6779","volume":"87","author":"K Leeper","year":"2002","unstructured":"Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P (2002) Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol 87:52\u201356","journal-title":"Gynecol Oncol"},{"key":"222_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JMJ Piek","year":"2001","unstructured":"Piek JMJ, van Diest PJ, Zweemer RP et al (2001) Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195:451\u2013456","journal-title":"J Pathol"},{"key":"222_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jnci\/94.1.61","volume":"94","author":"JP Geisler","year":"2002","unstructured":"Geisler JP, Hatterman-Zogg MA, Rathe JA, Buller RE (2002) Frequency of BRCA1 dysfunction in ovarian cancer. J Natl Cancer Inst 94:61\u201367","journal-title":"J Natl Cancer Inst"},{"key":"222_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B","volume":"87","author":"PA Russell","year":"2000","unstructured":"Russell PA, Pharoah PDP, De Foy K et al (2000) Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Int J Cancer 87:317\u2013321","journal-title":"Int J Cancer"},{"key":"222_CR8","first-page":"4151","volume":"62","author":"KYK Chan","year":"2002","unstructured":"Chan KYK, Oz\u00e7elik H, Cheung ANY, Ngan HYS, Khoo US (2002) Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 62:4151\u20134156","journal-title":"Cancer Res"},{"key":"222_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/humu.10181","volume":"21","author":"M Schuijer","year":"2003","unstructured":"Schuijer M, Berns EM (2003) TP53 and ovarian cancer. Hum Mutat 21:285\u2013291","journal-title":"Hum Mutat"},{"key":"222_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"The Cancer Genome Atlas Research N","year":"2011","unstructured":"The Cancer Genome Atlas Research N (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474:609\u2013615","journal-title":"Nature"},{"key":"222_CR11","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1073\/pnas.90.11.4961","volume":"90","author":"J Kupryja\u0144czyk","year":"1993","unstructured":"Kupryja\u0144czyk J, Thor AD, Beauchamp R et al (1993) p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A 90:4961\u20134965","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0046-8177(93)90212-Y","volume":"24","author":"S Bosari","year":"1993","unstructured":"Bosari S, Viale G, Radaelli U, Bossi P, Bonoldi E, Coggi G (1993) p53 accumulation in ovarian carcinomas and its prognostic implications. Hum Pathol 24:1175\u20131179","journal-title":"Hum Pathol"},{"key":"222_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/jcp.52.5.372","volume":"52","author":"RP Zweemer","year":"1999","unstructured":"Zweemer RP, Shaw PA, Verheijen RM et al (1999) Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations. J Clin Pathol 52:372\u2013375","journal-title":"J Clin Pathol"},{"key":"222_CR14","doi-asserted-by":"publisher","first-page":"e8404","DOI":"10.1371\/journal.pone.0008404","volume":"4","author":"BA Quinn","year":"2009","unstructured":"Quinn BA, Brake T, Hua X et al (2009) Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. PLoS One 4:e8404","journal-title":"PLoS One"},{"key":"222_CR15","doi-asserted-by":"crossref","unstructured":"Clark-Knowles KV, Senterman MK, Collins O, Vanderhyden BC (2009) Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas. PLoS One 4:e8534","DOI":"10.1371\/journal.pone.0008534"},{"key":"222_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yexcr.2006.09.026","volume":"313","author":"KV Clark-Knowles","year":"2007","unstructured":"Clark-Knowles KV, Garson K, Jonkers J, Vanderhyden BC (2007) Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Exp Cell Res 313:133\u2013145","journal-title":"Exp Cell Res"},{"key":"222_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cub.2005.01.052","volume":"15","author":"R Chodankar","year":"2005","unstructured":"Chodankar R, Kwang S, Sangiorgi F et al (2005) Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr Biol 15:561\u2013565","journal-title":"Curr Biol"},{"key":"222_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/0008-5472.CAN-09-3232","volume":"70","author":"H Hong","year":"2010","unstructured":"Hong H, Yen H-Y, Brockmeyer A et al (2010) Changes in the mouse estrus cycle in response to Brca1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res 70:221\u2013228","journal-title":"Cancer Res"},{"key":"222_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0303-7207(00)00340-3","volume":"172","author":"JA Parrott","year":"2001","unstructured":"Parrott JA, Doraiswamy V, Kim G, Mosher R, Skinner MK (2001) Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol Cell Endocrinol 172:213\u2013222","journal-title":"Mol Cell Endocrinol"},{"key":"222_CR20","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1001283","volume":"363","author":"A Radu","year":"2010","unstructured":"Radu A, Pichon C, Camparo P et al (2010) Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med 363:1621\u20131630","journal-title":"N Engl J Med"},{"issue":"151","key":"222_CR21","first-page":"1","volume":"87","author":"KA Walters","year":"2012","unstructured":"Walters KA, Middleton LJ, Joseph SR et al (2012) Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility. Biol Reprod 87(151):1\u201311","journal-title":"Biol Reprod"},{"key":"222_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/gene.10100","volume":"33","author":"C L\u00e9cureuil","year":"2002","unstructured":"L\u00e9cureuil C, Fontaine I, Crepieux P, Guillou F (2002) Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice. Genesis 33:114\u2013118","journal-title":"Genesis"},{"key":"222_CR23","doi-asserted-by":"publisher","first-page":"22629","DOI":"10.1073\/pnas.1012141108","volume":"107","author":"CM Allan","year":"2010","unstructured":"Allan CM, Kalak R, Dunstan CR et al (2010) Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci U S A 107:22629\u201322634","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"298","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF (1971) Incessant ovulation? A factor in ovarian neoplasia? Lancet 298:163","journal-title":"Lancet"},{"key":"222_CR25","first-page":"717","volume":"71","author":"D Cramer","year":"1983","unstructured":"Cramer D, Welch WR (1983) Determinants of ovarian cancer rsik II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717\u2013721","journal-title":"J Natl Cancer Inst"},{"key":"222_CR26","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1210\/en.2009-0416","volume":"150","author":"P Lim","year":"2009","unstructured":"Lim P, Robson M, Spaliviero J et al (2009) Sertoli cell androgen receptor DNA binding domain is essential for the completion of spermatogenesis. Endocrinology 150:4755\u20134765","journal-title":"Endocrinology"},{"key":"222_CR27","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.1073\/pnas.0702969104","volume":"104","author":"X Liu","year":"2007","unstructured":"Liu X, Holstege H, van der Gulden H et al (2007) Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci U S A 104:12111\u201312116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","volume":"4","author":"T Jacks","year":"1994","unstructured":"Jacks T, Remington L, Williams BO et al (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4:1\u20137","journal-title":"Curr Biol"},{"key":"222_CR29","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1210\/endo.142.6.8092","volume":"142","author":"CM Allan","year":"2001","unstructured":"Allan CM, Haywood M, Swaraj S et al (2001) A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions. Endocrinology 142:2213\u20132220","journal-title":"Endocrinology"},{"key":"222_CR30","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1210\/endo.136.12.7588276","volume":"136","author":"J Singh","year":"1995","unstructured":"Singh J, O\u2019Neill C, Handelsman DJ (1995) Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology 136:5311\u20135321","journal-title":"Endocrinology"},{"key":"222_CR31","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","volume":"23","author":"F Schwenk","year":"1995","unstructured":"Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23:5080\u20135081","journal-title":"Nucleic Acids Res"},{"key":"222_CR32","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1210\/en.2007-0046","volume":"148","author":"KJ McTavish","year":"2007","unstructured":"McTavish KJ, Jimenez M, Walters KA et al (2007) Rising follicle-stimulating hormone levels with age accelerate female reproductive failure. Endocrinology 148:4432\u20134439","journal-title":"Endocrinology"},{"key":"222_CR33","doi-asserted-by":"publisher","first-page":"8413","DOI":"10.1038\/sj.onc.1206888","volume":"22","author":"RV Mettus","year":"2003","unstructured":"Mettus RV, Rane SG (2003) Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice. Oncogene 22:8413\u20138421","journal-title":"Oncogene"},{"key":"222_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1095\/biolreprod.104.033654","volume":"72","author":"M Jimenez","year":"2005","unstructured":"Jimenez M, Spaliviero JA, Grootenhuis AJ, Verhagen J, Allan CM, Handelsman DJ (2005) Validation of an ultrasensitive and specific immunofluorometric assay for mouse follicle-stimulating hormone. Biol Reprod 72:78\u201385","journal-title":"Biol Reprod"},{"key":"222_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/toxsci\/kfj086","volume":"90","author":"P Desmeules","year":"2006","unstructured":"Desmeules P, Devine PJ (2006) Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries. Toxicol Sci 90:500\u2013509","journal-title":"Toxicol Sci"},{"key":"222_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/jrf.0.0590267","volume":"59","author":"RH Braw","year":"1980","unstructured":"Braw RH, Tsafriri A (1980) Effect of PMSG on follicular atresia in the immature rat ovary. J Reprod Fertil 59:267\u2013272","journal-title":"J Reprod Fertil"},{"key":"222_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/IGC.0b013e3181bda1cb","volume":"20","author":"A Labiche","year":"2010","unstructured":"Labiche A, Heutte N, Herlin P, Chasle J, Gauduchon P, Elie N (2010) Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma. Int J Gynecol Cancer 20:28\u201333","journal-title":"Int J Gynecol Cancer"},{"key":"222_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5566\/ias.v24.p85-93","volume":"24","author":"N Elie","year":"2011","unstructured":"Elie N, Labiche A, Michels J-J, Herlin P (2011) Control of low-resolution scanning of ovarian tumor stromal compartment. Image Anal Stereol 24:85\u201393","journal-title":"Image Anal Stereol"},{"key":"222_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jsbmb.2010.02.001","volume":"121","author":"KM McNamara","year":"2010","unstructured":"McNamara KM, Harwood DT, Simanainen U, Walters KA, Jimenez M, Handelsman DJ (2010) Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol 121:611\u2013618","journal-title":"J Steroid Biochem Mol Biol"},{"key":"222_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2009.09.003","volume":"409","author":"DT Harwood","year":"2009","unstructured":"Harwood DT, Handelsman DJ (2009) Development and validation of a sensitive liquid chromatography\u2013tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta 409:78\u201384","journal-title":"Clin Chim Acta"},{"key":"222_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1095\/biolreprod66.1.77","volume":"66","author":"G Cheng","year":"2002","unstructured":"Cheng G, Weihua Z, M\u00e4kinen S et al (2002) A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod 66:77\u201384","journal-title":"Biol Reprod"},{"key":"222_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/bcr37","volume":"2","author":"V Yu","year":"2000","unstructured":"Yu V (2000) Caretaker Brca1: keeping the genome in the straight and narrow. Breast Cancer Res 2:82\u201385","journal-title":"Breast Cancer Res"},{"key":"222_CR43","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida K, Miki Y (2004) Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 95:866\u2013871","journal-title":"Cancer Sci"},{"key":"222_CR44","first-page":"3351","volume":"57","author":"JS Larson","year":"1997","unstructured":"Larson JS, Tonkinson JL, Lai MT (1997) A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. Cancer Res 57:3351\u20133355","journal-title":"Cancer Res"},{"key":"222_CR45","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1038\/sj.onc.1208492","volume":"24","author":"Y Yan","year":"2005","unstructured":"Yan Y, Spieker RS, Kim M, Stoeger SM, Cowan KH (2005) BRCA1-mediated G2\/M cell cycle arrest requires ERK1\/2 kinase activation. Oncogene 24:3285\u20133296","journal-title":"Oncogene"},{"key":"222_CR46","first-page":"1","volume":"13","author":"N Shao","year":"1996","unstructured":"Shao N, Chai YL, Shyam E, Reddy P, Rao VN (1996) Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13:1\u20137","journal-title":"Oncogene"},{"key":"222_CR47","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/nar\/gkl010","volume":"34","author":"C-X Deng","year":"2006","unstructured":"Deng C-X (2006) BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34:1416\u20131426","journal-title":"Nucleic Acids Res"},{"key":"222_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/8743","volume":"22","author":"X Xu","year":"1999","unstructured":"Xu X, Wagner KU, Larson D et al (1999) Conditional mutation of Brca 1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37\u201343","journal-title":"Nat Genet"},{"key":"222_CR49","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1073\/pnas.95.23.13612","volume":"95","author":"A Dierich","year":"1998","unstructured":"Dierich A, Sairam MR, Monaco L et al (1998) Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A 95:13612\u201313617","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR50","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","volume":"25","author":"TJ Colgan","year":"2001","unstructured":"Colgan TJ, Murphy J, Cole DEC, Narod S, Rosen B (2001) Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol 25:1283\u20131289","journal-title":"Am J Surg Pathol"},{"key":"222_CR51","doi-asserted-by":"crossref","unstructured":"Kurman RJ, Shih I-M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34:433\u2013443","DOI":"10.1097\/PAS.0b013e3181cf3d79"},{"key":"222_CR52","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Shih I-M (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm. Hum Pathol 42:918\u2013931","journal-title":"Hum Pathol"},{"key":"222_CR53","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","volume":"9","author":"L Dubeau","year":"2008","unstructured":"Dubeau L (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol 9:1191\u20131197","journal-title":"Lancet Oncol"},{"key":"222_CR54","doi-asserted-by":"publisher","first-page":"19643","DOI":"10.1074\/jbc.M311780200","volume":"279","author":"M Ouchi","year":"2004","unstructured":"Ouchi M, Fujiuchi N, Sasai K et al (2004) BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition. J Biol Chem 279:19643\u201319648","journal-title":"J Biol Chem"},{"key":"222_CR55","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1158\/1078-0432.CCR-13-0066","volume":"19","author":"J George","year":"2013","unstructured":"George J, Alsop K, Etemadmoghadam D et al (2013) Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations. Clin Cancer Res 19:3474\u20133484","journal-title":"Clin Cancer Res"},{"key":"222_CR56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","volume":"92","author":"M Esteller","year":"2000","unstructured":"Esteller M, Silva JM, Dominguez G et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564\u2013569","journal-title":"J Natl Cancer Inst"},{"key":"222_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/gcc.2870130310","volume":"13","author":"R Cornelis","year":"1995","unstructured":"Cornelis R, Neuhausen S, Arason A et al (1995) Allele loss rate at 17q12-q21 in breast and ovarian tumors from 52 germ line BRCA1-mutation carriers. Genes Chromosom Cancer 13:203\u2013210","journal-title":"Genes Chromosom Cancer"},{"key":"222_CR58","first-page":"1","volume":"10","author":"VL Cressman","year":"1999","unstructured":"Cressman VL, Backlund DC, Hicks EM, Gowen LC, Godfrey V, Koller BH (1999) Mammary tumor formation in p53- and BRCA1-deficient mice. Cell Growth Differ Mol Biol J Am Assoc Cancer Res 10:1\u201310","journal-title":"Cell Growth Differ Mol Biol J Am Assoc Cancer Res"},{"key":"222_CR59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29:418\u2013425","journal-title":"Nat Genet"},{"key":"222_CR60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature11154","volume":"486","author":"S Banerji","year":"2012","unstructured":"Banerji S, Cibulskis K, Rangel-Escareno C et al (2012) Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486:405\u2013409","journal-title":"Nature"},{"key":"222_CR61","first-page":"3459","volume":"63","author":"A Flesken-Nikitin","year":"2003","unstructured":"Flesken-Nikitin A, Choi K-C, Eng JP, Shmidt EN, Nikitin AY (2003) Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res 63:3459\u20133463","journal-title":"Cancer Res"},{"key":"222_CR62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"222_CR63","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-11-3834","volume":"72","author":"L Szabova","year":"2012","unstructured":"Szabova L, Yin C, Bupp S et al (2012) Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res 72:4141\u20134153","journal-title":"Cancer Res"},{"key":"222_CR64","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets R, Wyant GA, Muto KW et al (2013) Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in brca;Tp53;pten models. Cancer Cell 24:751\u2013765","journal-title":"Cancer Cell"},{"key":"222_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/gyno.1999.5628","volume":"76","author":"W Zheng","year":"2000","unstructured":"Zheng W, Lu JJ, Luo F et al (2000) Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol 76:80\u201388","journal-title":"Gynecol Oncol"},{"key":"222_CR66","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.1038\/sj.onc.1208985","volume":"24","author":"Y Hu","year":"2005","unstructured":"Hu Y, Ghosh S, Amleh A et al (2005) Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression. Oncogene 24:8343\u20138348","journal-title":"Oncogene"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-015-0222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-015-0222-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-015-0222-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-015-0222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T17:46:33Z","timestamp":1609263993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-015-0222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1007\/s12672-015-0222-5","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]},"assertion":[{"value":"18 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}